-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Connect Biopharma Hldgs, Lowers Price Target to $6

Benzinga·09/16/2026 13:23:54
Listen to the news
Canaccord Genuity analyst Edward Nash maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and lowers the price target from $7 to $6.